FDA 表示,Abeona 必须满足额外的CMC 要求才...查看全文
Abeona Therapeutics(ABEO)06-21 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024527 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)06-08 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023117 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)06-08 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023122 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)06-12 19:05
$Abeona Therapeutics(ABEO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-023541 Act: 33 Size: 1 MB 网页链接查看全文
Abeona Therapeutics(ABEO)06-18 05:25
$Abeona Therapeutics(ABEO)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-024171 Act: 33 Size: 646 KB 网页链接查看全文
Abeona Therapeutics(ABEO)07-10 04:35
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640 Act: 34 Size: 362 KB 网页链接查看全文
Abeona Therapeutics(ABEO)07-10 04:45
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)07-10 04:45
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641 Size: 4 KB 网页链接查看全文
Abeona Therapeutics(ABEO)05-04 05:25
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-017768 Act: 34 Size: 1 MB 网页链接查看全文
chuminhua04-23 11:46
4/22,Abeona Therapeutics $Abeona Therapeutics(ABEO)$ 表示,其针对隐性营养不良性大疱性表皮松解症 (DEB) 患者的自体基因校正细胞疗法 prademagene zamikeracel (pz-cel) 收到了 FDA 的完整回复信 (CRL)。 该公司股价周一盘后交易中暴跌 51%。
FDA 表示,Abeona 必须满足额外的CMC 要求才...查看全文
产业链观察2023-11-27 22:14
#药闻简讯# $Abeona Therapeutics(ABEO)$ FDA接受并授予Pz-cel BLA的优先审评。
PDUFA 05/25/24.
FDA目前不打算举办AdComm查看全文
SeekingBiotech2023-07-29 20:29
ABEO announced that it has completed the submission of the briefing package to the FDA for its pre-Biologics License Application (BLA) meeting in August 2023$Abeona Therapeutics(ABEO)$查看全文
牛唐2023-07-10 20:22
医药板块速评(2022.07.07)
1、多个7月有数据发布的BIotech股价启动,哪些有配置机会?
2、$Abeona Therapeutics(ABEO)、$居里(CRIS)纷纷增发,是否有上车机会?
3、$Wolfspeed(WOLF)$ 、$ETFMG Alternative Harvest ETF(MJ)$ 、$油气服务ETF-Market Vectors(OIH)$ 等异动,后续走势...查看全文
SeekingBiotech2023-06-09 22:39
$Abeona Therapeutics(ABEO)$
基因治疗候选新药。需要补充材料。
营养不良性大疱性表皮松解症(DEB)(包括隐性营养不良性大疱性表皮松解症-RDEB)
Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101查看全文
智通财经APP获悉,11月27日,Abeona Therapeutics(ABEO.US)宣布,美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel,EB-101)的生物制品许可申请(BLA),并授予优先审评资格,该疗法是一款自体、COL7A1基因校正表皮片,用于隐性... 网页链接
$Abeona Therapeutics(ABEO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-09 AccNo: 0001144204-19-038872 Size: 3 MB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001144204-19-038892 Size: 37 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Abeona Therapeutics(ABEO)$ 8-K - Current report Filed: 2019-07-25 AccNo: 0001144204-19-035879 Size: 19 KBItem 8.01: Other Events 网页链接
$Abeona Therapeutics(ABEO)$ 8-K - Current report Filed: 2019-07-25 AccNo: 0001144204-19-035881 Size: 41 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-10 AccNo: 0000315066-19-001597 Size: 8 KB 网页链接
$Abeona Therapeutics(ABEO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-07-05 AccNo: 0001319244-19-000059 Size: 114 KB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K - Current report Filed: 2019-05-29 AccNo: 0001144204-19-028638 Size: 25 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Abeona Therapeutics(ABEO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-10 AccNo: 0001144204-19-025271 Size: 3 MB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K - Current report Filed: 2019-05-10 AccNo: 0001144204-19-025280 Size: 47 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Abeona Therapeutics(ABEO)$ 内部交易: 2019-04-11,Director,Buono Stefano ,买入,49020普通股, $7.91